Headlines

Inovio Pharmaceuticals Stock Went Down By Over 20% In The Last 10 Sessions

(VIANEWS) – Shares of Inovio Pharmaceuticals (NASDAQ: INO) dropped by a staggering 20.65% in 10 sessions from $1.84 at 2023-02-06, to $1.46 at 10:42 EST on Tuesday, following the last session’s upward trend. NASDAQ is sliding 1.41% to $11,621.63, after two consecutive sessions in a row of losses. Inovio Pharmaceuticals’s last close was $1.53, 61.75%…

Read More

Less Than One Hour Before The NASDAQ Open, Xenetic Biosciences Is Up By 6%

(VIANEWS) – The NASDAQ opens in less than one hour and Xenetic Biosciences‘s pre-market value is already 6.99% up. Xenetic Biosciences’s last close was $0.58, 53.64% below its 52-week high of $1.25. The last session, NASDAQ finished with Xenetic Biosciences (XBIO) jumping 3.98% to $0.58. NASDAQ dropped 0.58% to $11,787.27, after two sequential sessions in…

Read More

Less Than One Hour Before The NASDAQ Open, Xenetic Biosciences Is Up By 6%

(VIANEWS) – The NASDAQ opens in less than one hour and Xenetic Biosciences‘s pre-market value is already 6.99% up. Xenetic Biosciences’s last close was $0.58, 53.64% under its 52-week high of $1.25. The last session, NASDAQ finished with Xenetic Biosciences (XBIO) jumping 3.98% to $0.58. NASDAQ slid 0.58% to $11,787.27, after two consecutive sessions in…

Read More

Pacific Biosciences Of California Already 6% Down, Almost Two Hours Before The Market Open

(VIANEWS) – The NASDAQ opens in less than two hours and Pacific Biosciences of California‘s pre-market value is already 6.12% down. Pacific Biosciences of California’s last close was $10.45, 26.41% below its 52-week high of $14.20. The last session, NASDAQ ended with Pacific Biosciences of California (PACB) sliding 3.24% to $10.45. NASDAQ fell 0.58% to…

Read More